Wein Matthew
- SEC CIK
- 0002009713
In the past year, 5 open-market sale filings worth $2.62K and no purchases.
Current role at each company
- MGX Metagenomi Therapeutics, Inc.See Remarksas of Sep 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.62K
- 5 filings
- Net
- −$2.62K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wein Matthew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 (view filing)3:47 PM ET | Sep 8 | 2 days | Wein MatthewSee Remarks | SSale | −358 | $1.16 | −$414.71 | −0.3%126.1K after | |
| Jun 10, 2026 (view filing) | Jun 5 | 5 daysLate | Wein MatthewSee Remarks | SSale | −558 | $1.30 | −$725.4 | −0.4%126.5K after | |
| Mar 9, 2026 (view filing) | Mar 5 | 4 days | Wein MatthewSee Remarks | SSale | −482 | $1.60 | −$771.2 | −0.4%114.5K after | |
| Dec 8, 2025 (view filing) | Dec 5 | 3 days | Wein MatthewSee Remarks | SSale | −199 | $1.77 | −$352.23 | −0.2%115.0K after | |
| Dec 1, 2025 (view filing) | Sep 5 | 87 daysLate | Wein MatthewSee Remarks | SSale | −199 | $1.81 | −$360.19 | −1.0%19.2K after | |
| Jun 9, 2025 (view filing) | Jun 6 | 3 days | Wein MatthewSee Remarks | SSale | −199 | $1.75 | −$348.25 | −1.2%16.7K after | |
| Mar 7, 2025 (view filing) | Mar 5 | 2 days | Wein MatthewSee Remarks | SSale | −930 | $1.87 | −$1.74K | −8.9%9.47K after |